Correlation Between Viridian Therapeutics and Ocular Therapeutix
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Ocular Therapeutix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Ocular Therapeutix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Ocular Therapeutix, you can compare the effects of market volatilities on Viridian Therapeutics and Ocular Therapeutix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Ocular Therapeutix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Ocular Therapeutix.
Diversification Opportunities for Viridian Therapeutics and Ocular Therapeutix
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Ocular is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Ocular Therapeutix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocular Therapeutix and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Ocular Therapeutix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocular Therapeutix has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Ocular Therapeutix go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Ocular Therapeutix
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 4.96 times less return on investment than Ocular Therapeutix. But when comparing it to its historical volatility, Viridian Therapeutics is 1.24 times less risky than Ocular Therapeutix. It trades about 0.01 of its potential returns per unit of risk. Ocular Therapeutix is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 761.00 in Ocular Therapeutix on August 31, 2024 and sell it today you would earn a total of 228.00 from holding Ocular Therapeutix or generate 29.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Ocular Therapeutix
Performance |
| Timeline |
| Viridian Therapeutics |
| Ocular Therapeutix |
Viridian Therapeutics and Ocular Therapeutix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Ocular Therapeutix
The main advantage of trading using opposite Viridian Therapeutics and Ocular Therapeutix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Ocular Therapeutix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will offset losses from the drop in Ocular Therapeutix's long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Ocular Therapeutix vs. CytomX Therapeutics | Ocular Therapeutix vs. Assembly Biosciences | Ocular Therapeutix vs. Spero Therapeutics | Ocular Therapeutix vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets |